Govt Extends Deadline to Class C & D Medical Device Manufacturers Facing Licence Approval Delays October 13, 2023 The Indian government has announced a six-month extension for existing manufacturers and importers of high-risk medical devices who have applied for licences.
IIT-G Alumni Led Startup Develops POCT Device '˜Mobilab' for Early NCD Diagnosis October 11, 2023 Mobilab uses an IoT-enabled Android app and can conduct around 150 tests on a single battery charge. This feature fosters a digitally connected ecosystem, extending its reach to remote regions and catering to the healthcare needs of underserved populations.
ICMR Calls Indian Scientist & Researchers to Submit Expressions of Interest Related to Cancer Screening & Diagnostic October 11, 2023 This initiative aims to enhance and elevate the quality of cancer screening within the current healthcare system, utilising established and validated approaches.
Serum-Mylab's Cy-TB Test Integrated into National Tuberculosis Elimination Program October 10, 2023 This development aims to enhance the diagnosis of latent TB infections, addressing a major healthcare concern in India.
Cytiva Expands Operations in India with New Pune Manufacturing Facility & Training Centre October 9, 2023 US-based Cytiva, a global life sciences company, has unveiled its latest manufacturing facility and Experience Centre in Pune, India.
After a Long Hiatus, Govt Now Mulling Deadline Extension to Medical Device Manufacturers October 6, 2023 This potential extension is in response to delays in granting new licenses required to sustain production, reported the Economic Times.
US-Based BVP & IFC Look to Sell Their 30% Stake in Indian Dialysis Chain NephroPlus October 5, 2023 US-based Bessemer Venture Partners (BVP) and the World Bank's International Finance Corporation (IFC) are set to sell approximately 30% of their stakes in NephroPlus, India's largest dialysis chain.
Medical Devices Industry in Turmoil as New Law Restrains 200 Producers October 5, 2023 The medical devices industry is facing a crisis as more than 200 manufacturers have been compelled to halt the supply of their products due to the non-approval of their manufacturing licence applications under a recently implemented law before the cutoff date of October 1, 2023.
High-Risk Medical Device Manufacturers Halt Production Facing Regulatory Hurdles October 4, 2023 The recent regulatory changes dictate that medical devices categorised as class C and D, encompassing items such as ventilators, imaging equipment, oxygen therapy equipment, nebulisers, x-ray equipment, surgical robots, and oncology treatment linear accelerators, are prohibited from being sold without a valid manufacturing licence from October 1 onwards.
Gleneagles Hospital Launches RecoSMA Technology for Rapid Wound Healing & Tissue Repair Issues October 4, 2023 Gleneagles Hospital, Kengeri in Bengaluru has unveiled RecoSMA (Reconstruction by Spatially Modulated Ablation) laser technology. This advanced technology is set to transform patient care by offering precise, non-invasive solutions for rapid wound healing and tissue repair.
Centre Approves INR 6,000 Cr Investment for Pharma & Medical Devices under PLI Scheme: Amit Shah October 3, 2023 This investment aims to foster the production of APIs and KSMs, essential components in drug and medical device manufacturing, as part of the government's holistic approach to cultivate a robust ecosystem for the domestic production of these vital healthcare components.
Agilus Diagnostics, Formerly SRL Files DRHP for IPO October 3, 2023 Agilus Diagnostics, formerly known as SRL, has submitted its draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) for its forthcoming initial public offering (IPO).